Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).
about
Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytesIn vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemiaInteraction between rifabutin and human immunodeficiency virus type 1: inhibition of replication, cytopathic effect, and reverse transcriptase in vitroCombinations of isoprinosine and 3'-azido-3'-deoxythymidine in lymphocytes infected with human immunodeficiency virus type 1Selective inhibition of human immunodeficiency virus type 1 replication by the (-) but not the (+) enantiomer of gossypolDMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyproteinChronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interactionLong lasting control of viral rebound with a new drug ABX464 targeting Rev - mediated viral RNA biogenesis.Simple assay to screen for inhibitors of interaction between the human immunodeficiency virus envelope glycoprotein and its cellular receptor, CD4Differential effects of human immunodeficiency virus isolates on beta-chemokine and gamma interferon production and on cell proliferation.Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.Selective replication of simian immunodeficiency virus in a subset of CD4+ lymphocytes.Induction of anti-HIV neutralizing antibodies by synthetic peptides.Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV).Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120.Optimization of Critical Hairpin Features Allows miRNA-based Gene Knockdown Upon Single-copy Transduction.Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.HIV transmission to female sexual partners of HIV antibody-positive hemophiliacs.Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1.Influence of quinacrine and chloroquine on the in vitro 3'-azido-3'-deoxythymidine antiretroviral effect.Antibody response to human immunodeficiency virus in homosexual men. Relation of antibody specificity, titer, and isotype to clinical status, severity of immunodeficiency, and disease progressionPolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro.Metal-based formulations with high microbicidal activity.Lentivector Knockdown of CCR5 in Hematopoietic Stem and Progenitor Cells Confers Functional and Persistent HIV-1 Resistance in Humanized Mice.Mechanisms of human immunodeficiency virus Type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibodyLoss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication.Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. Structural enzymatic analysisMolecular determinants of the ratio of inert to infectious virus particles.Reduced viral load and lack of CD4 depletion in SCID-hu mice infected with Rev-independent clones of human immunodeficiency virus type 1.Antigen detection for human immunodeficiency virus.Distinguishing features of an infectious molecular clone of the highly divergent and noncytopathic human immunodeficiency virus type 2 UC1 strainTwo mechanisms of soluble CD4 (sCD4)-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) infectivity and their relation to primary HIV-1 isolates with reduced sensitivity to sCD4.Quantitation of human immunodeficiency virus type 1 infection kinetics.Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibodyTwo receptors are required for antibody-dependent enhancement of human immunodeficiency virus type 1 infection: CD4 and Fc gamma R.Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals.Activation of a beta-galactosidase recombinant provirus: application to titration of human immunodeficiency virus (HIV) and HIV-infected cells.
P2860
Q24562117-73BD722C-9D5C-40C8-89A2-60423F05CB7FQ24563909-8C443871-CBD6-4C21-A2A5-3D7BBEE1AC5FQ28339082-A9E279D7-D2A8-411F-8301-557372347B7DQ28339702-C7BD05D7-1AFA-452F-A0C0-B0615D108E71Q28354386-980CD4F8-4AFC-481F-8856-D19C6526EF17Q28369100-F4CE5097-5CD1-4CBA-B11C-CE661410417BQ28731004-C6344AD7-C65F-41E3-86D6-8CFB8F58361EQ30373903-D909785B-90BB-48A8-A3A7-EBA0C9F830CFQ33220705-EB01CFE4-F8B4-40DC-9535-2E4B0A726B29Q33641854-EABD3CBE-1E3A-4808-ABD2-84541626642AQ33648180-391A12CD-AC2F-4A3E-BE8A-0ACAB5932197Q33784777-099D8023-FA7F-4686-A3A5-F7F932FA079BQ33854075-4E915BC1-7872-4F1B-AB89-B0DDB03E8050Q33880796-36479302-8CAE-497C-8C37-5BFEDA257FEEQ33933098-A3A24CE6-C4A9-4139-947A-F7338507BD8BQ34060230-C8472F97-2CF0-4589-BDCC-D13346B68882Q34221143-2A65E626-BC8A-437C-9B5F-8668F4F3DB5AQ34440338-6A6C7ADB-5B7C-43C9-99D4-F86B4554BF39Q34550838-E2102CC6-004D-4B0C-8D55-89B6A6643EA2Q34675187-918FE822-95AB-40EF-8FE0-50E752D970E3Q34949513-976CC6BF-846A-40E1-B749-C4D4C93A66AAQ35126450-C1DDA6DA-D895-4708-B40C-5E23385A9543Q35191410-CE35386A-1149-4DC2-A0B8-E4203BB33196Q35576665-24F6A33E-FFF3-4E3A-A774-D1F5770EA42AQ35583044-6C11496D-CCB8-40E5-A738-3BCB1E99CD60Q35693622-28DF942A-569A-4F15-822B-2181B4F8E610Q35745432-2BA11209-2A09-4D35-A977-4BB06D100ED6Q35866030-91442BC0-1BFF-43ED-BD3B-67A743280A56Q36355743-674EAEFB-C3E7-4D20-B3B7-ECC97F57A60DQ36356138-CE43304D-0D72-4878-8D34-D7423856DDE8Q36494676-821C0AB5-1FE0-4075-8F2B-148BA71CE647Q36549397-5B4FD0E0-5041-495F-A859-E43EFF32EA83Q36635240-A1555346-4343-4EA5-B3A6-26585D042C41Q36641861-3627F78F-5219-43B0-BDFB-3621FF5AFD8FQ36643604-19C57D69-E2C2-4714-B1FC-CBA263494946Q36686530-CFBDCBD1-4E6D-49BD-AA92-3811697EC935Q36782627-0B7AC890-0C50-4F19-B4CB-1634A013B1E3Q36793493-8ED12AA4-CFB5-4885-84E8-F2C539601363Q36803017-103EC6E8-CF68-4B20-B3D9-8D4782717E4DQ36806944-0ECB28F4-8635-4F78-854A-7DB07FC0EF7C
P2860
Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Immunoassay for the detection ...... opathy-associated virus (LAV).
@en
Immunoassay for the detection ...... opathy-associated virus (LAV).
@nl
type
label
Immunoassay for the detection ...... opathy-associated virus (LAV).
@en
Immunoassay for the detection ...... opathy-associated virus (LAV).
@nl
prefLabel
Immunoassay for the detection ...... opathy-associated virus (LAV).
@en
Immunoassay for the detection ...... opathy-associated virus (LAV).
@nl
P2093
P1476
Immunoassay for the detection ...... opathy-associated virus (LAV).
@en
P2093
Cabridilla CD
Feorino PM
Francis DP
Kalyanaraman VS
Kennedy MS
McDougal JS
P304
P356
10.1016/0022-1759(85)90489-2
P577
1985-01-01T00:00:00Z